Velogenic newcastle disease virus as an oncolytic virotherapeutics: In vitro characterization

Applied Biochemistry and Biotechnology

Volumn 167, Issue 7, 2012, Pages 2005-2022

  Kumar, Rajiv ^a   Tiwari, Ashok K ^a   Chaturvedi, Uttara ^a   Kumar, G Ravi ^a   Sahoo, Aditya P ^a   Rajmani, R S ^a   Saxena, Lovleen ^a   Saxena, Shikha ^a   Tiwari, Sangeeta ^b   Kumar, Sudesh ^a  

^a INDIAN VETERINARY RESEARCH INSTITUTE   (India)

^b M J P ROHILKHAND UNIVERSITY   (India)

Author keywords

Adaptation; Apoptosis; HeLa cells; NDV; Oncolytic virotherapy

Indexed keywords

ADAPTATION; CANCER CELLS; CANCER THERAPY; CASPASES; CYTOTOXIC; DOMESTIC ANIMALS; HELA CELL; IN-VITRO; NDV; PATHOTYPE; PRECLINICAL STUDIES; TREATMENT MODALITY; UP-REGULATION; VIROTHERAPY;

DISEASES; VIRUSES;

CELL DEATH;

CASPASE 3; CASPASE 8; CASPASE 9; COMPLEMENTARY DNA; RNA; STAUROSPORINE; TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND;

ADAPTATION; APOPTOSIS; ARTICLE; CANCER THERAPY; CELL VIABILITY; CONTROLLED STUDY; CULTURE MEDIUM; CYTOTOXICITY; DNA FRAGMENTATION; ENZYME ACTIVATION; FLOW CYTOMETRY; GENE EXPRESSION; HELA CELL; HEMAGGLUTINATION INHIBITION; HUMAN; HUMAN CELL; IN VITRO STUDY; MITOCHONDRIAL MEMBRANE POTENTIAL; NEWCASTLE DISEASE PARAMYXOVIRUS; NONHUMAN; ONCOLYTIC VIROTHERAPY; REAL TIME POLYMERASE CHAIN REACTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TISSUE CULTURE; VIRUS HEMAGGLUTINATION; VIRUS LOAD; VIRUS VIRULENCE;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; ANNEXIN A5; BIOLOGICAL TRANSPORT; CASPASES; CELL NUCLEUS; CELL SURVIVAL; CHICKENS; CHROMATIN; DNA FRAGMENTATION; G1 PHASE; HELA CELLS; HEMAGGLUTINATION; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; KINETICS; MEMBRANE POTENTIAL, MITOCHONDRIAL; NEWCASTLE DISEASE; NEWCASTLE DISEASE VIRUS; ONCOLYTIC VIROTHERAPY; PHOSPHATIDYLSERINES; PROPIDIUM; REAL-TIME POLYMERASE CHAIN REACTION; STAINING AND LABELING; TNF-RELATED APOPTOSIS-INDUCING LIGAND; UP-REGULATION;

ANIMALIA; NEWCASTLE DISEASE VIRUS;

EID: 84866364621     PISSN: 02732289     EISSN: 15590291     Source Type: Journal    
DOI: 10.1007/s12010-012-9700-1     Document Type: Article

References (59)

1. Dey, M., Ulasov, I. V., & Lesniak, M. S. (2010). Cancer Letters, 289, 1-10.
2. Lazar, I., Yaacov, B., Shiloach, T., Eliahoo, E., Kadouri, L., Lotem, M., et al. (2010). Journal of Virology, 84(1), 639-646.
3. Zemp, F. J., Corredor, J. C., Lun, X., Muruve, D. A., & Forsyth, P. A. (2010). Cytokine Growth F. R, 21, 103-117.
4. Mayo, M. A. (2002). Archives of Virology, 147(8), 1655-1656.
5. Alexander, D. J. (1997). In diseases of poultry, 10th ed. (B.W. Calnek (ed.),), Iowa State University Press, Iowa, pp. 541-569.
6. Schirrmacher, V., Griesbach, A., & Ahlert, T. (2001). International Journal of Oncology, 18, 945-952.
7. Freeman, A. I., Zakay-Rones, Z., Gomori, J. M., Linetsky, E., Rasooly, L., Greenbaum, E., et al. (2006). Molecular Therapy, 13, 221-228.
8. Cassel, W. A., & Garret, R. E. (1965). Cancer, 18, 863-868.
9. Cassel, W. A., & Murray, D. R. (1992). Medicine Oncology Tumor Pharmacy, 9(4), 169-171.
10. Pecora, A. L., Rizvi, N., Cohen, G. I., Meropol, N. J., Sterman, D., Marshall, J. L., et al. (2002). Journal of Clinical Oncology, 20, 2251-2266.
11. Steiner, H. H., Bonsanto, M. M., Beckhove, P., Brysch, M., Geletneky, K., Ahmadi, R., et al. (2004). Journal of Clinical Oncology, 22(21), 4272-4281.
12. Csatary, L. K., Moss, R. W., Beuth, J., Torocsik, B., Szeberenyi, J., & Bakacs, T. (1999). Anticancer Research, 19, 635-638.
13. Csatary, L. K., Gosztonyi, G., Szeberenyi, J., Fabian, Z., Liszka, V., Bodey, B., et al. (2004). Journal of Neuro-Oncology, 67, 83-93.
14. Lorence, R. M., Pecora, A. L., Major, P. P., Hotte, S. J., Laurie, S. A., Roberts, M. S., et al. (2003). Current Opinion in Molecular Therapeutics, 5, 618-624.
15. Lorence, R. M., Roberts, M. S., O'Neil, J. D., Groene, W. S., Miller, J. A., Mueller, S. N., et al. (2007). Current Cancer Drug Targets, 7, 157-167.
16. Ali, R., Alabsi, A. M., Ali, A. M., Ainideris, Omar, A. R., & Khatijah, Y. (2011). International Journal of Cancer Research, 7(1), 25-35.
17. Liang, W., Wang, H., Sun, T. M., Yao, W. Q., Chen, L. L., Jin, Y., et al. (2003). World Journal of Gastroenterology, 9(3), 495-498.
18. Csatary, L. K., Eckhardt, S., Bukosza, I., Czegledi, F., Fenyvesi, C., Gergely, P., et al. (1993). Cancer Detection and Prevention, 17, 619-627.
19. Hotte, J. S., Lorence, R. M., Hirte, H. W., Polawski, S. R., Bamat, M. K., O'Neil, J. D., et al. (2007). Clinical Cancer Research, 13(3), 977-985.
20. Omar, A. R., Ali, A. I. A. M., Othman, F., Yusoff, K., Abdullah, J. M., Wali, H. S. M., et al. (2003). Malaysian Journal of Medical Sciences, 10(1), 4-12.
21. Reichard, K. W., Lorence, R. M., Cascino, C. J., Peeples, M. E., Walter, R. J., Fernando, M. B., et al. (1992). Journal of Surgical Research, 52, 448-453.
22. Bar-Eli, N., Giloh, H., Schlesinger, M., & Zakay-Rones, Z. (1996). Journal of Cancer Research and Clinical Oncology, 122, 409-415.
23. Yaacov, B., Eliahoo, E., Lazar, I., Ben-Shlomo, M., Greenbaum, I., Panet, A., et al. (2008). Cancer Gene Therapy, 15, 795-807.
24. Krishnamurthy, S., Takimoto, T., Scroggs, R. A., & Portner, A. (2006). Journal of Virology, 80, 5145-5155.
25. Mansour, M., Palese, P., & Zamarin, D. (2011). Journal of Virology, 84(12), 6015-6023.
26. Nykky, J., Tuusa, J. E., Kirjavainen, S., Vuento, M., & Gilbert, L. (2010). International Journal of Nanomedicine, 5, 417-428.
27. Nanthakumar, T., Kataria, R. S., Tiwari, A. K., Butchiah, G., & Kataria, J. M. (2000). Veterinary Research Communications, 24, 275-286.
28. Kalali, B. N., Kollisch, G., Mages, J., Muller, T., Bauer, T., Wagner, H., et al. (2008). Journal of Immunology, 181, 2694-2704.
29. Schmittgen, T. D., & Livak, K. J. (2008). Nature Protocols, 3(6), 1101-1108.
30. Available from www.oie.int/fileadmin/Home/eng/2.03.14, Accessed June 20, 2011.
31. Kenis, H., Genterbern, H. V., Rinia, H. A., Narula, T., & Hafstra, L. (2004). Journal of Biological Chemistry, 279, 52623-52629.
32. Hughes, D. and Mehmet H. (2003). Cell proliferation and apoptosis, 1st edn., (pp.341-342), BIOS Scientific, Oxford.
33. Blau, H. M., Chiu, C. P., & Webster, C. (1983). Cell, 32(4), 1171-1180.
34. Herrmann, M., Lorenz, H. M., Voll, R., Grunke, M., Woith, W., & Kalde, J. R. (1994). Nucleic Acids Research, 22(24), 5506-5507.
35. Ravindra, P. V., Tiwari, A. K., Ratta, B., Chaturvedi, U., Palia, S. K., & Chauhan, R. S. (2009). Virus Research, 141, 13-20.
36. Vigil, A., Park, M. S., Martinez, O., Chua, M. A., Xiao, S., Cros, J. F., et al. (2007). Cancer Research, 67 (17), 8285-8292.
37. Ahlert, T., & Schirrmacher, V. (1990). Cancer Research, 50(18), 5962-5968.
38. Zorn, U., Dallman, I., Grosse, J., Kirchner, H., Poliwoda, H., & Atzpodien, J. (1994). Cancer Biotherapy, 9, 225-235.
39. Washburn, B., & Schirrmacher, V. (2002). International Journal of Oncology, 21, 85-93.
40. Fabian, Z., Csatary, C. M., Szeberenyi, J., & Csatary, L. K. (2007). Journal of Virology, 81, 2817-2830.
41. Ahamed, T., Hossain, K. M., Billah, M. M., Islam, K. M. D., Ahasan, M. M., & Islam, M. E. (2004). International Journal of Poultry Science, 3(2), 153-156.
42. Ravindra, P. V., Ratta, B., Chaturvedi, U., Palia, S. K., Subudhi, P. K., & Tiwari, A. K. (2008). Journal of Hellenic Veterinarian Medical Society, 59(4), 341-345.
43. Mendy, M. E., Kaye, S., Sande, M. V., Rayco-Solon, P., Waight, P. A., Shipton, D., et al. (2006). Virology Journal, 3, 23.
44. Lay, M. L. J., Lucas, R. M., Ratnamohan, M., Taylor, J., & Ponsonby, A. L. (2010). Virology Journal, 7, 252.
45. Li, G., Li, W., Guoc, F., Xuc, S., Zhaod, N., Chena, S., et al. (2010). Journal of Virological Methods, 165, 9-14.
46. Katsates, V., Petsa, A., Felesakis, A., Paparidis, Z., Nikolaidou, E., Gargani, S., et al. (2009). Laboratory Medicine, 40(9), 557-560.
47. Fink, S. L., & Cookson, B. T. (2005). Infection and Immunity, 73(4), 1907-1916.
48. Kroemer, G., Zamzami, N., & Susin, S. A. (1997). Immunology Today, 18, 44-51.
49. Krysko, D. V., Berghe, V., D'Herde, K., & Vandenabeele, P. (2008). Methods, 44(3), 205-221.
50. Vermes, I., Haanen, C., Steffens-Nakken, H., & Reutelingperger, C. (1995). Journal of Immunological Methods, 184, 39-51.
51. Mo, H., & Elson, C. E. (1999). Journal of Nutrition, 129, 804-813.
52. Kraupp, B. G., Ruttkay-Nedecky, B., Koudelka, H., Bukowska, K., Bursch, W., & Schulte-Hermann, R. (1995). Hepatology, 21(5), 1465-1468.
53. Heatwole V. M. (1999) In: Methods in molecular biology, vol. 115 III (Javois, L. C. ed.) Humana Press Inc. Totowa, NJ, pp. 141-148.
54. Kerr, J. F. R., Wyllie, A. H., & Currie, A. R. (1972). British Journal of Cancer, 26, 239-257.
55. Couderc, T., Guivel-Benhassine, F., Calaora, V., Gosselin, A. S., & Blondel, B. (2002). Journal of General Virology, 83, 1925-1930.
56. Zamzami, N., Marchetti, P., Castedo, M., Zanin, C., Vayssiere, J. L., Petit, P. X., et al. (1995). The Journal of Experimental Medicine, 181, 1661-1672.
57. Muhlenbeck, F., Haas, E., Schwenzer, R., Schubert, G., Grell, M., Smith, C., et al. (1998). Journal of Biological Chemistry, 273(49), 33091-33098.
58. Washburn,W.,Weigand, M. A., Grosse-Wilde, A., Janke, M., Stahl, H., Riser, E., et al. (2003). Journal of Immunology, 170, 1814-1821.
59. Litz, J., Carlson, P., Warshamana-Greene, S. G., Grant, S., & Krystal, G. W. (2003). Clinical Cancer Research, 9, 4586-4594.9.